|
Volumn 92, Issue 3, 2002, Pages 191-193
|
Antiretroviral therapy in South Africa - Can we do it?
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIRETROVIRUS AGENT;
PROTEINASE INHIBITOR;
TUBERCULOSTATIC AGENT;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
BIOCHEMISTRY;
CLINICAL OBSERVATION;
DEATH;
DISEASE TRANSMISSION;
DRUG COST;
DRUG EFFICACY;
DRUG QUALITY;
DRUG SAFETY;
HEALTH CARE ACCESS;
HEALTH CARE FACILITY;
HEALTH SERVICE;
HEMATOLOGY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
PATIENT COMPLIANCE;
PATIENT COUNSELING;
PATIENT MONITORING;
PSYCHOSOCIAL CARE;
REVIEW;
SOUTH AFRICA;
TUBERCULOSIS;
TUBERCULOSIS CONTROL;
WORLD HEALTH ORGANIZATION;
ANTI-HIV AGENTS;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
HIV INFECTIONS;
HUMANS;
SOUTH AFRICA;
|
EID: 0036259064
PISSN: 02569574
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (4)
|
References (11)
|